Owlstone Medical, the global leader in Breath Biopsy® technology for early disease detection and precision medicine, announced it has been awarded up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) to advance the Platform Optimizing SynBio…
NanoPhoria Bioscience, a next-generation biotech company pioneering precision nanomedicine for cardiovascular and chronic diseases, today announced the first close of its €83.5 million Series A financing round. The round was co-led by XGEN Venture, Sofinnova Partners, and CDP Venture Capital,…
Bruker Corporation today announced the receipt of multiple new orders for its advanced Nuclear Magnetic Resonance (NMR) instrumentation from three leading U.S. research institutions — the New York Structural Biology Center (NYSBC), the University of Delaware, and Northwestern University. Supported…
Kihealth Inc., a precision diagnostics company advancing early disease detection, has announced the successful close of its $5 million oversubscribed seed round, signaling strong investor confidence in its pioneering approach to metabolic health and chronic disease prevention. The funding will…
CTMC, a joint venture between Resilience and The University of Texas MD Anderson Cancer Center, has announced a strategic collaboration with Einstein Hospital Israelita in São Paulo, Brazil, to accelerate the development, manufacturing, and adoption of advanced cell therapies across…
Cartography Biosciences, Inc., a biotechnology company pioneering next-generation T-cell–engaging bispecific and multispecific antibody therapeutics, announced the successful close of a $67 million Series B financing round. The new capital will be used to advance the company’s lead program, CBI-1214, into…
Monash University, Australia’s largest university and one of the world’s top 50 research institutions, has announced the launch of the Monash Boston Hub, a new strategic base designed to strengthen the university’s collaborations with North American and European biotechnology and…
55 North, the world’s largest dedicated quantum technology venture capital fund, has announced the first close of its €300 million Fund I at €134 million, marking a significant milestone for both the European and global quantum ecosystems. The fund establishes…
Genialis, the RNA biomarker company, announced a new collaboration with Cleveland Clinic, one of the world’s leading academic medical centers, to co-develop AI-driven tools that aim to personalize treatment for patients with pancreatic ductal adenocarcinoma (PDAC)—the most prevalent and deadliest…
Thermo Fisher Scientific and AstraZeneca BioVentureHub Announce Strategic R&D Partnership to Advance Life Science Innovation. The PPD™ clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, today announced a new research and development (R&D) partnership…